Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: July 28, 2026
Assessing Willingness and Barriers to Clinical Trial Participation Among Patients With Cancer in Post-Conflict Syria: A Mixed-Methods Study.
Journal: JCO global oncology
Published: June 10, 2026
Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studies.
Journal: Drugs in context
Published: July 30, 2025
Plain language summary of the EVOKE-01 study of sacituzumab govitecan vs docetaxel in patients with non-small cell lung cancer.
Journal: Future oncology (London, England)
Published: May 15, 2025
Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: May 06, 2025
Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC.
Journal: JTO clinical and research reports
Published: June 13, 2024
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 06, 2024
Considerations for selecting second-line treatment in patients with progressive small cell lung cancer and the use of Lurbinectedin in this setting.
Journal: Cancer treatment and research communications
Published: January 02, 2024
Breast cancer quality of care in Syria: screening, diagnosis, and staging.
Journal: BMC cancer
Published: May 02, 2023
Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 04, 2022
Last Updated: 09/26/2026